Subject: MJNA Garners More Coverage on Mexican News Station About Benefits of CBD

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MJNA Garners More Coverage on Mexican News Station About Benefits of CBD
Hot Stock to WatchHot Stock to Watch

Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)


Price: 0.0848

Change (%): + 0.0038 (4.74)

Volume: 3,635,318
MJNA Chart

Medical Marijuana, Inc. Announces Prominent Coverage on Mexican News Station About Benefits of CBD and Global CBD Policy

SAN DIEGO, Nov. 2, 2017 /PRNewswire/ - Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Raúl Elizalde, General Manager of subsidiary HempMeds® Mexico, was recently interviewed on Azteca TV Mexico, resulting in notable media coverage of his upcoming speaking engagement at the World Health Organization Drug Scheduling Convention on Psychotropic Substances on November 6, 2017.

According to the interview, Elizalde explained that “The World Health Organization will address cannabidiol along with a list of other substances that they are analyzing to know if they need to be updated and scheduled as psychoactive substances. Cannabidiol is not psychoactive and we wonder how cannabidiol ended up in a list of substances with some synthetic ones like ketamine and vigabatrin.” He later went on to say that “part of what I’m going to do at the World Health Organization is to talk to them and explain that cannabidiol has no side effects and that there is a difference [between CBD and marijuana].”

“We couldn’t be more enthusiastic about Raúl representing the Medical Marijuana, Inc, portfolio of companies and our mission to further access of CBD on such a large global stage,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are optimistic that he will help the World Health Organization and the United Nations see that botanical CBD derived from hemp should be viewed as a nutritional supplement.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks